DS
ETNB

David Shaw’s 89bio ETNB Stock Holding History

David Shaw’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,208
Closed -$885K – 4699
2025
Q3 		$885K Buy
+60,208
New +$614K ﹤0.01% 3537
2024
Q2 		– Sell
-55,493
Closed -$646K – 4578
2024
Q1 		$646K Buy
55,493
+41,536
+298% +$460K ﹤0.01% 3357
2023
Q4 		$156K Sell
13,957
-4,348
-24% -$40K ﹤0.01% 3920
2023
Q3 		$283K Sell
18,305
-390,941
-96% -$6.56M ﹤0.01% 3639
2023
Q2 		$7.76M Buy
409,246
+252,743
+161% +$4.44M 0.01% 1547
2023
Q1 		$2.38M Buy
+156,503
New +$2.04M ﹤0.01% 2560
2022
Q3 		– Sell
-94,036
Closed -$303K – 5278
2022
Q2 		$303K Buy
94,036
+28,128
+43% +$84.9K ﹤0.01% 4359
2022
Q1 		$248K Buy
+65,908
New +$425K ﹤0.01% 4749

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

David Shaw's ETNB Position: Q4 2025 in Review

David Shaw sold out of 89bio (ETNB) in Q4 2025, closing a stake of 60,208 shares — an estimated $885K sold.

David Shaw first reported a position in ETNB in Q1 2022 and held it in 8 quarters. The position peaked at $7.76M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • David Shaw reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • David Shaw sold 60,208 89bio shares in Q4 2025, an estimated $885K.
  • David Shaw first reported a position in 89bio in Q1 2022 and held it in 8 quarters.
  • David Shaw's 89bio position peaked at $7.76M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.